Net Cash Provided by (Used in) Operating Activities |
-15.8M |
USD |
+68.4% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
70.8M |
USD |
+172% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-1.47M |
USD |
+45% |
Q1 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
700M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
133M |
shares |
+10.2% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
55.3M |
USD |
|
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
89.3M |
USD |
-33.3% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
140M |
USD |
+19.5% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
141M |
USD |
+19.5% |
Q4 2024 |
FY 2024 |
Payments to Acquire Property, Plant, and Equipment |
672K |
USD |
+93.1% |
Q1 2024 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-81.1M |
USD |
+64.4% |
Q2 2025 |
Q2 2025 |
Operating Lease, Liability, Current |
894K |
USD |
-21.3% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
73.2M |
USD |
+23.4% |
Q4 2024 |
FY 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Depreciation, Depletion and Amortization |
622K |
USD |
0% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
574K |
USD |
+31.4% |
Q4 2024 |
FY 2024 |
Share-based Payment Arrangement, Expense |
13.9M |
USD |
-22% |
Q2 2025 |
Q2 2025 |
Interest Expense |
1.66M |
USD |
-8.76% |
Q1 2025 |
Q1 2025 |